An internationally recognized testing institution, assisting enterprises in achieving technological advancement.
ZHONGXI Testing has obtained inspection qualification certifications from multiple countries and regions worldwide. We possess a senior testing team and advanced testing methods, providing independent, impartial, and professional third-party verification services for global carbon projects.
Certified by multiple international standards such as CNAS, VCS, and GS, with reports universally applicable worldwide.
Covering 140+ countries and regions, it supports on-site detection and remote verification in multiple languages.
Adopt standard experimental methods to ensure accurate and reliable data.
If you are searching for protein affinity testing, you likely need to quantify the binding strength between a protein and its ligand – whether for drug discovery (antibody-antigen, small molecule‑target), biologics development, receptor characterization, or quality control of therapeutic proteins. Affinity parameters (KD, kon, koff, IC50, and thermodynamic signatures) determine biological activity, stability, and safety. Our laboratory provides comprehensive protein affinity analysis using orthogonal advanced platforms – from label‑free kinetic measurement to high‑throughput screening and full thermodynamic profiling – following ICH and FDA guidance for biophysical characterization.

We do not merely report a single KD value. Our platform includes Surface Plasmon Resonance (SPR) (Biacore 8K+ and Biacore S200) for real‑time binding kinetics: association rate (kon), dissociation rate (koff), and affinity constant (KD) with detection limits down to 0.1 nM for small molecules and pM for antibodies. For label‑free thermodynamics, we use Isothermal Titration Calorimetry (ITC) (MicroCal PEAQ‑ITC) to measure binding stoichiometry (n), enthalpy change (ΔH), entropy change (ΔS), and Gibbs free energy (ΔG) simultaneously. To screen large libraries or weak interactions, we offer MicroScale Thermophoresis (MST) (Monolith NT.115) and Bio‑Layer Interferometry (BLI) (Octet R8) with low sample consumption (≤10 µL). For high‑throughput affinity ranking, we perform Differential Scanning Fluorimetry (DSF) and AlphaLISA as orthogonal counterscreens. We also provide Kinetic Exclusion Assay (KinExA) for sub‑pM KD measurements where SPR and ITC lack sensitivity.
Key parameters we routinely measure:
- Equilibrium dissociation constant (KD) – from 1 fM to 10 mM depending on method.
- Association rate (kon) and dissociation rate (koff) – SPR/BLI, range 10³–10⁷ M⁻¹s⁻¹ and 10⁻⁶–10⁰ s⁻¹.
- Binding stoichiometry (n) – ITC and MST.
- Thermodynamic parameters (ΔH, ΔS, ΔG) – ITC at multiple temperatures.
- IC50 and EC50 for competitive binding – AlphaLISA, ELISA, or MST.
- Binding cooperativity (Hill coefficient) – for multi‑site interactions.
- pH, ionic strength, and temperature dependence of affinity – automated SPR/ITC.
- Affinity for modified ligands (mutations, post‑translational modifications) – all methods adaptable.
Most routine labs offer only single‑technique KD reports, which can miss artifacts (mass transport, avidity, aggregation). We provide cross‑validated affinity data using at least two orthogonal methods (e.g., SPR + ITC or MST + KinExA) to ensure biological relevance. For membrane proteins, we perform lipoprotein reconstitution or nanodisc‑based SPR/ITC. We determine conformation‑selective affinities using hydrogen‑deuterium exchange mass spectrometry (HDX‑MS) to map binding‑induced conformational changes and identify binding epitopes. For complex biological matrices (serum, cell lysate), we use pull‑down affinity capture coupled with LC‑MS/MS to measure specific binding in native conditions while quantifying non‑specific interactions.
Our advanced capabilities include:
- Temperature‑dependent ITC – measure ΔCp (heat capacity change) to predict binding entropy and drug design optimization.
- High‑throughput SPR (up to 384 analytes per run) – for epitope binning, off‑rate ranking, and library screening.
- Affinity under flow and shear stress – microfluidic SPR simulating physiological flow.
- Kinetics of conformational change (two‑state or induced fit models) – global fitting of SPR data with Clamp or Scrubber.
- Free ligand concentration measurement by Rapid Equilibrium Dialysis (RED) + LC‑MS – for true KD of highly lipophilic or adhesive compounds.
- Binding affinity in crowded or viscous solutions (PEG, serum) – MST and ITC adaptable to complex buffers.
- Real‑time cell‑based affinity measurement (Bio‑Layer Interferometry on cell surfaces) – for membrane‑bound receptors.
We routinely achieve measurement uncertainties: KD ±5–15% (SPR/BLI), ΔH ±0.1 kcal/mol, stoichiometry n ±2% using validated reference standards (e.g., carbonic anhydrase/benzenesulfonamide, protein A/IgG). All methods follow ICH Q2(R1) for validation, and FDA guidance for biophysical characterization of biologics.
1. ISO/IEC 17025:2017 and GLP‑compliant platforms – all instruments are qualified, and methods validated for pharmaceutical, biologics, and academic research.
2. Orthogonal cross‑validation by 5+ technologies – we do not rely on a single technique; we confirm affinity using SPR, ITC, MST, KinExA, or BLI, eliminating false positives/negatives due to aggregation or mass transport.
3. Ultra‑high and ultra‑low affinity coverage – from 1 fM (KinExA) to 10 mM (weak MST) – no binding is too weak or too tight for our panel.
4. Thermodynamic profiling beyond KD – we provide ΔH, ΔS, ΔCp, and stoichiometry, enabling rational optimization of binding thermodynamics.
5. Membrane protein and challenging target expertise – we handle GPCRs, ion channels, and aggregation‑prone proteins using nanodiscs, LUVs, and proprietary buffer optimization.
6. Root cause analysis for unexpected affinity changes – we identify whether altered binding is due to protein aggregation, misfolding, post‑translational modification, or ligand degradation, using SEC‑MALS, MS, and DSF.
7. Fast turnaround and complete data transparency – routine affinity screening (SPR or MST) completed in 3–5 business days; full kinetic + thermodynamic profiling in 10–15 business days. You receive raw sensorgrams, ITC thermograms, MST traces, fitting reports, and all raw data files for publication or regulatory submission.
8. Custom assay development for novel targets – covalent inhibitors, intrinsically disordered proteins, or unusual buffers – we develop robust, validated affinity assays within 3–4 weeks.
9. Competitive pricing for full affinity panels – bundling SPR kinetics, ITC thermodynamics, and MST cross‑validation costs 35% less than separate orders.
We have successfully completed over 1,200 protein affinity projects for biopharma companies (monoclonal antibodies, ADCs, small molecule inhibitors), diagnostic developers, and academic labs. Our team includes PhD biophysicists and protein chemists with expertise in binding thermodynamics and kinetic modeling.
Describe your protein target (source, purity, concentration), ligand (small molecule, peptide, antibody, nucleic acid), required buffer conditions, and expected affinity range (if known). We will provide a free technical consultation and a fixed‑price quote. Whether you need a single KD measurement or full kinetic/thermodynamic characterization for regulatory submission, we deliver deep, accurate, and orthogonal‑validated protein affinity testing tailored to your biological question.